1. Home
  2. KAR vs ADPT Comparison

KAR vs ADPT Comparison

Compare KAR & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KAR
  • ADPT
  • Stock Information
  • Founded
  • KAR 2006
  • ADPT 2009
  • Country
  • KAR United States
  • ADPT United States
  • Employees
  • KAR N/A
  • ADPT N/A
  • Industry
  • KAR Retail-Auto Dealers and Gas Stations
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KAR Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • KAR Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • KAR 2.6B
  • ADPT 2.6B
  • IPO Year
  • KAR 2009
  • ADPT 2019
  • Fundamental
  • Price
  • KAR $26.22
  • ADPT $17.47
  • Analyst Decision
  • KAR Hold
  • ADPT Strong Buy
  • Analyst Count
  • KAR 5
  • ADPT 10
  • Target Price
  • KAR $27.60
  • ADPT $15.10
  • AVG Volume (30 Days)
  • KAR 670.6K
  • ADPT 1.6M
  • Earning Date
  • KAR 11-05-2025
  • ADPT 11-05-2025
  • Dividend Yield
  • KAR N/A
  • ADPT N/A
  • EPS Growth
  • KAR 697.19
  • ADPT N/A
  • EPS
  • KAR 0.73
  • ADPT N/A
  • Revenue
  • KAR $1,856,600,000.00
  • ADPT $205,216,000.00
  • Revenue This Year
  • KAR $5.00
  • ADPT $34.41
  • Revenue Next Year
  • KAR $4.79
  • ADPT $14.03
  • P/E Ratio
  • KAR $35.98
  • ADPT N/A
  • Revenue Growth
  • KAR 7.20
  • ADPT 21.60
  • 52 Week Low
  • KAR $15.79
  • ADPT $4.27
  • 52 Week High
  • KAR $30.93
  • ADPT $17.89
  • Technical
  • Relative Strength Index (RSI)
  • KAR 36.88
  • ADPT 63.72
  • Support Level
  • KAR $26.02
  • ADPT $16.59
  • Resistance Level
  • KAR $27.06
  • ADPT $17.40
  • Average True Range (ATR)
  • KAR 0.56
  • ADPT 0.77
  • MACD
  • KAR 0.01
  • ADPT -0.06
  • Stochastic Oscillator
  • KAR 35.80
  • ADPT 84.46

About KAR OPENLANE Inc.

Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: